Health ❯ Medical Research

Clinical Trials

Drug Development Cancer Treatment Gene Therapy Neuroscience Neurology Animal Studies Spinal Cord Injury Immunotherapy Drug Efficacy Innovative Treatments

JW Pharmaceutical Licenses Korean Rights to Gan & Lee’s GLP-1 Drug in Deal Worth Up to $81 Million

The deal positions JW to start Phase 3 trials in South Korea this year.

Cornell Study Shows Reversible Male Contraception by Targeting Meiosis in Mice

Soleno Faces Securities Class Action Over DCCR Safety as Investors Weigh May 5 Lead‑Plaintiff Deadline

Antidepressant Fluvoxamine Eases Long COVID Fatigue in Randomized Trial

FDA Approves First Therapy for Acquired Hypothalamic Obesity, Expanding Rhythm’s Imcivree

Humacyte Raises $20 Million in Direct Offering and Lands Saudi Symvess Purchase Pact

Large Trial Finds No Acute COVID Benefit From Vitamin D, Hints at Fewer Long COVID Symptoms

Vertex’s IgA Nephropathy Drug Hits Phase 3 Goals, FDA Filing Slated for March

Study Identifies FOXJ3 Mutations as a Cause of Focal Cortical Dysplasia and Drug-Resistant Epilepsy

Polilaminina Enters Regulated Testing as Lead Researcher Moves to Correct Preprint

Early Trials of Gene Regulation Drug Cut Dravet Seizures by Up to 91%, NEJM Reports

Brazil Moves to Bolster IP After Polylaminin Patent Lapse as First Safety Trial Nears

Laser-Guided Tumor Ablation Plus Pembrolizumab More Than Doubles Survival in Recurrent Astrocytoma Trial

Anvisa Authorizes First Safety Trial of Experimental Polilaminin for Acute Spinal Cord Injury

Astellas–Vir Prostate Cancer Alliance Launches With New Data as VIR Stock Surges

Keio Spinout Plans iPS Cell Trial for Spinal Cord Injury as Early as 2027

Polilaminina Enters Anvisa-Approved Phase 1 as Off-Protocol Use Expands and Scientists Urge Caution

Ultrasound-Activated Nanobubbles Break Tumor Barriers in Mouse Study

Lilly Combo of Zepbound and Taltz Tops Taltz Alone in Late-Stage Psoriasis Trials

Northern Ireland Suspends Role in UK Puberty Blocker Trial During Judicial Review